Red blood cell transfusions in children awaiting heart transplantation

Pediatric Transplantation

Volumn 15, Issue 7, 2011, Pages 728-732

  Mahle, William T ^a   Berg, Alexandria M ^a   Kanter, Kirk R ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

anemia; heart transplantation; transfusion

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN;

ARTICLE; CHILD; ERYTHROCYTE TRANSFUSION; HEART FAILURE; HEART TRANSPLANTATION; HEMOGLOBIN BLOOD LEVEL; HOSPITALIZATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; SCHOOL CHILD;

ADOLESCENT; ANEMIA; CHILD; CHILD, PRESCHOOL; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; ERYTHROPOIETIN; HEART TRANSPLANTATION; HUMANS; INFANT; MODELS, STATISTICAL; REGRESSION ANALYSIS; RISK; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; WAITING LISTS;

EID: 80055022200     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2011.01561.x     Document Type: Article

References (26)

1. Kuo JA, Maher KO, Kirshbom PM, et al., Red blood cell transfusion for infants with single-ventricle physiology. Pediatr Cardiol 2011: 32: 461-468.
2. Salvin JW, Scheurer MA, Laussen PC, et al., Blood transfusion after pediatric cardiac surgery is associated with prolonged hospital stay. Ann Thorac Surg 2011: 91: 204-210.
3. Wylie MC, Graham DA, Potter-Bynoe G, et al., Risk factors for central line-associated bloodstream infection in pediatric intensive care units. Infect Control Hosp Epidemiol 2010: 31: 1049-1056.
4. Sanfilippo FP, Bollinger RR, Macqueen JM, et al., A randomized study comparing leukocyte-depleted versus packed red cell transfusions in prospective cadaver renal allograft recipients. Transfusion 1985: 25: 116-119.
5. Katz SD, Mancini D, Androne AS, et al., Treatment of anemia in patients with chronic heart failure. J Card Fail 2004: 10: S13-S16.
6. Noumi B, Teruya S, Salomon S, et al., Blood volume measurements in patients with heart failure and a preserved ejection fraction: Implications for diagnosing anemia. Congest Heart Fail 2011: 17: 14-18.
7. Beck Da SL, Rohde LE, Clausell N,. Etiology and management of anemia in patients with heart failure: How much iron is missing? Congest Heart Fail 2008: 14: 25-30.
8. Androne AS, Katz SD, Lund L, et al., Hemodilution is common in patients with advanced heart failure. Circulation 2003: 107: 226-229.
9. Torella F, Haynes SL, Mccollum CN,. Cerebral and peripheral near-infrared spectroscopy: An alternative transfusion trigger? Vox Sang 2002: 83: 254-257.
10. Lacroix J, Hebert PC, Hutchison JS, et al., Transfusion strategies for patients in pediatric intensive care units. N Engl J Med 2007: 356: 1609-1619.
11. Spinella PC, Dressler A, Tucci M, et al., Survey of transfusion policies at US and Canadian children's hospitals in 2008 and 2009. Transfusion 2010: 50: 2328-2335.
12. Timmer SA, De BK, Knaapen P, et al., The potential role of erythropoietin in chronic heart failure: From the correction of anemia to improved perfusion and reduced apoptosis? J Card Fail 2009: 15: 353-361.
13. Tehrani F, Dhesi P, Daneshvar D, et al., Erythropoiesis stimulating agents in heart failure patients with anemia: A meta-analysis. Cardiovasc Drugs Ther 2009: 23: 511-518.
14. Ghali JK, Anand IS, Abraham WT, et al., Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia. Circulation 2008: 117: 526-535.
15. Ponikowski P, Anker SD, Szachniewicz J, et al., Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: A randomized, double-blind, placebo-controlled trial. J Am Coll Cardiol 2007: 49: 753-762.
16. Port RE, Mehls O,. Erythropoietin dosing in children with chronic kidney disease: Based on body size or on hemoglobin deficit? Pediatr Nephrol 2009: 24: 435-437.
17. Shimpo H, Mizumoto T, Onoda K, et al., Erythropoietin in pediatric cardiac surgery: Clinical efficacy and effective dose. Chest 1997: 111: 1565-1570.
18. Aronson D, Dann EJ, Bonstein L, et al., Impact of red blood cell transfusion on clinical outcomes in patients with acute myocardial infarction. Am J Cardiol 2008: 102: 115-119.
19. Soosay A, O'Neill D, Counihan A, et al., Causes of sensitisation in patients awaiting renal transplantation in Ireland. Ir Med J 2003: 96: 109-112.
20. Deierhoi MH, Barger BO, Hudson SL, et al., The effect of erythropoietin and blood transfusions on highly sensitized patients on a single cadaver renal allograft waiting list. Transplantation 1992: 53: 363-368.
21. Coppage M, Baker M, Fialkow L, et al., Lack of significant de novo HLA allosensitization in ventricular assist device recipients transfused with leukoreduced, ABO identical blood products. Hum Immunol 2009: 70: 413-416.
22. Shaddy RE, Hunter DD, Osborn KA, et al., Prospective analysis of HLA immunogenicity of cryopreserved valved allografts used in pediatric heart surgery. Circulation 1996: 94: 1063-1067.
23. Tsau PH, Arabia FA, Toporoff B, et al., Positive panel reactive antibody titers in patients bridged to transplantation with a mechanical assist device: Risk factors and treatment. ASAIO J 1998: 44: M634-M637.
24. Stringham JC, Bull DA, Fuller TC, et al., Avoidance of cellular blood product transfusions in LVAD recipients does not prevent HLA allosensitization. J Heart Lung Transplant 1999: 18: 160-165.
25. Massad MG, Cook DJ, Schmitt SK, et al., Factors influencing HLA sensitization in implantable LVAD recipients. Ann Thorac Surg 1997: 64: 1120-1125.
26. Drakos SG, Nastasiou-Nana MI, Malliaras KG, et al., Anemia in chronic heart failure. Congest Heart Fail 2009: 15: 87-92.